Literature DB >> 8189505

Cloning and expression of an equine herpesvirus 1 origin-binding protein.

D W Martin1, S Deb.   

Abstract

Equine herpesvirus 1 (EHV-1) is an important pathogen of horses and is closely related to several important human pathogens, herpes simplex virus types 1 and 2 (HSV-1 and HSV-2) and varicella-zoster virus. The EHV-1 genome contains open reading frames similar in sequence to the HSV-1 replication genes. PCR was used to clone EHV-1 gene 53, which is similar in sequence to the HSV-1 UL9 gene. The gene 53 product has regions of striking similarity to the HSV-1 UL9 and VZV gene 51 products. In vitro transcription and translation of this gene generated a protein of 87 kDa as measured by sodium dodecyl sulfate-polyacrylamide gel electrophoresis. Further characterization of this protein was accomplished through the use of gel shift analysis. The in vitro-synthesized protein bound sequence specifically to EHV-1 OriS as well as HSV-1 OriS. A site was used in gel shift analysis to show that the EHV-1 origin-binding protein bound to the same consensus site as the HSV-1 origin-binding protein, 5'-CGTTCGCACTT-3'. Using a nuclear extract of EHV-1-infected RK13 cells, we have identified an activity that interacts similarly with this consensus site. In gel shift assays, the retarded band arising from the nuclear extract migrated similarly to the retarded band arising from in vitro-translated EHV-1 gene 53. An N-terminal deletion of EHV-1 gene 53 was also created, expressed in vitro, and used in gel shift assays to localize the DNA-binding domain. Results of these experiments indicated that amino acids 1 to 499 were dispensable for binding and that the C-terminal fragment (amino acids 500 to 888) recognized the same consensus site as did the wild-type protein. Thus, the product of EHV-1 gene 53 is an origin-binding protein with a high degree of similarity to the HSV-1 and varicella-zoster virus origin-binding proteins and possibly serves as the initiator of DNA replication in EHV-1.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8189505      PMCID: PMC236872     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  21 in total

1.  Analysis of the herpes simplex virus type 1 OriS sequence: mapping of functional domains.

Authors:  D W Martin; S P Deb; J S Klauer; S Deb
Journal:  J Virol       Date:  1991-08       Impact factor: 5.103

2.  The herpes simplex virus 1 origin binding protein: a DNA helicase.

Authors:  R C Bruckner; J J Crute; M S Dodson; I R Lehman
Journal:  J Biol Chem       Date:  1991-02-05       Impact factor: 5.157

3.  A 269-amino-acid segment with a pseudo-leucine zipper and a helix-turn-helix motif codes for the sequence-specific DNA-binding domain of herpes simplex virus type 1 origin-binding protein.

Authors:  S Deb; S P Deb
Journal:  J Virol       Date:  1991-06       Impact factor: 5.103

4.  Two binding sites for the herpes simplex virus type 1 UL9 protein are required for efficient activity of the oriS replication origin.

Authors:  H M Weir; N D Stow
Journal:  J Gen Virol       Date:  1990-06       Impact factor: 3.891

5.  A new superfamily of replicative proteins.

Authors:  T C Hodgman
Journal:  Nature       Date:  1988-05-05       Impact factor: 49.962

6.  A DNA binding protein specific for an origin of replication of herpes simplex virus type 1.

Authors:  P Elias; M E O'Donnell; E S Mocarski; I R Lehman
Journal:  Proc Natl Acad Sci U S A       Date:  1986-09       Impact factor: 11.205

Review 7.  Molecular epizootiology, pathogenesis, and prophylaxis of equine herpesvirus-1 infections.

Authors:  G P Allen; J T Bryans
Journal:  Prog Vet Microbiol Immunol       Date:  1986

8.  Binding of the herpes simplex virus type 1 UL9 gene product to an origin of viral DNA replication.

Authors:  H M Weir; J M Calder; N D Stow
Journal:  Nucleic Acids Res       Date:  1989-02-25       Impact factor: 16.971

9.  Functional mapping and DNA sequence of an equine herpesvirus 1 origin of replication.

Authors:  R P Baumann; V R Yalamanchili; D J O'Callaghan
Journal:  J Virol       Date:  1989-03       Impact factor: 5.103

10.  Two related superfamilies of putative helicases involved in replication, recombination, repair and expression of DNA and RNA genomes.

Authors:  A E Gorbalenya; E V Koonin; A P Donchenko; V M Blinov
Journal:  Nucleic Acids Res       Date:  1989-06-26       Impact factor: 16.971

View more
  6 in total

1.  Functional characterization of Marek's disease virus (MDV) origin-binding protein (OBP): analysis of its origin-binding properties.

Authors:  T F Wu; H H Chen; H Wu
Journal:  Virus Genes       Date:  2001       Impact factor: 2.332

2.  Cloning and sequence analysis of a Marek's disease virus origin binding protein (OBP) reveals strict conservation of structural motifs among OBPs of divergent alphaherpesviruses.

Authors:  T F Wu; W Sun; M Boussaha; R Southwick; P M Coussens
Journal:  Virus Genes       Date:  1996       Impact factor: 2.332

3.  Varicella-zoster virus gene 51 complements a herpes simplex virus type 1 UL9 null mutant.

Authors:  D Chen; E C Stabell; P D Olivo
Journal:  J Virol       Date:  1995-07       Impact factor: 5.103

4.  Structural and biophysical characterization of the proteins interacting with the herpes simplex virus 1 origin of replication.

Authors:  Ioannis Manolaridis; Eleni Mumtsidu; Peter Konarev; Alexander M Makhov; Stephen W Fullerton; Andrea Sinz; Stefan Kalkhof; John E McGeehan; Peter D Cary; Jack D Griffith; Dmitri Svergun; Geoff G Kneale; Paul A Tucker
Journal:  J Biol Chem       Date:  2009-03-27       Impact factor: 5.157

5.  Human herpesvirus 6B origin-binding protein: DNA-binding domain and consensus binding sequence.

Authors:  N Inoue; P E Pellett
Journal:  J Virol       Date:  1995-08       Impact factor: 5.103

6.  Effective treatment of respiratory alphaherpesvirus infection using RNA interference.

Authors:  Amy Fulton; Sarah T Peters; Gillian A Perkins; Keith W Jarosinski; Armando Damiani; Margaret Brosnahan; Elizabeth L Buckles; Nikolaus Osterrieder; Gerlinde R Van de Walle
Journal:  PLoS One       Date:  2009-01-05       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.